<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font25 { font-size : 25; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font25">HIV </span>
   <span class="font25">and </span>
   <span class="font20">PrEP </span>
   <span class="font16">for </span>
   <span class="font15">resistance </span>
   <span class="font14">drug </span>
   <span class="font14">{background </span>
   <span class="font14">The </span>
   <span class="font14">was </span>
   <span class="font13">infection </span>
   <span class="font13">oral </span>
   <span class="font13">with </span>
   <span class="font13">from </span>
   <span class="font13">margin </span>
   <span class="font13">use </span>
   <span class="font13">viral </span>
   <span class="font13">{border-style </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">[]. </span>
   <span class="font12">testing </span>
   <span class="font12">were </span>
   <span class="font12">load </span>
   <span class="font12">month </span>
   <span class="font12">prophylaxis </span>
   <span class="font12">study </span>
   <span class="font12">that </span>
   <span class="font11">HIV- </span>
   <span class="font11">This </span>
   <span class="font11">case </span>
   <span class="font11">rapid </span>
   <span class="font11">antibody </span>
   <span class="font11">risk </span>
   <span class="font11">this </span>
   <span class="font11">using </span>
   <span class="font11">ART </span>
   <span class="font11">are </span>
   <span class="font11">data </span>
   <span class="font11">first </span>
   <span class="font11">infections </span>
   <span class="font11">mutations </span>
   <span class="font11">report </span>
   <span class="font11">which </span>
   <span class="font11">ARV </span>
   <span class="font11">clinical </span>
   <span class="font11">during </span>
   <span class="font11">had </span>
   <span class="font11">her </span>
   <span class="font11">participant </span>
   <span class="font11">pre-exposure </span>
   <span class="font11">px; </span>
   <span class="font11">sequencing </span>
   <span class="font11">therapy </span>
   <span class="font11">{font-family </span>
   <span class="font11">South </span>
   <span class="font11">available </span>
   <span class="font11">dual </span>
   <span class="font11">font-size </span>
   <span class="font11">high </span>
   <span class="font11">mutation </span>
   <span class="font11">not </span>
   <span class="font11">time </span>
   <span class="font11">transmitted </span>
   <span class="font10">Health </span>
   <span class="font10">Research </span>
   <span class="font10">University </span>
   <span class="font10">adherence </span>
   <span class="font10">all </span>
   <span class="font10">antiretroviral </span>
   <span class="font10">both </span>
   <span class="font10">conducted </span>
   <span class="font10">daily </span>
   <span class="font10">deep </span>
   <span class="font10">despite </span>
   <span class="font10">double; </span>
   <span class="font10">inhibitor </span>
   <span class="font10">initiated </span>
   <span class="font10">one </span>
   <span class="font10">tests </span>
   <span class="font10">who </span>
   <span class="font10">(London, </span>
   <span class="font10">Acquir </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Defic </span>
   <span class="font10">Immune </span>
   <span class="font10">acquisition </span>
   <span class="font10">after </span>
   <span class="font10">associated </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">breakthrough </span>
   <span class="font10">detection </span>
   <span class="font10">early </span>
   <span class="font10">importance </span>
   <span class="font10">increasing </span>
   <span class="font10">infected </span>
   <span class="font10">level </span>
   <span class="font10">levels </span>
   <span class="font10">low </span>
   <span class="font10">months </span>
   <span class="font10">partner </span>
   <span class="font10">preexposure </span>
   <span class="font10">prevention </span>
   <span class="font10">prolonged </span>
   <span class="font10">screening </span>
   <span class="font10">showed </span>
   <span class="font10">solid; </span>
   <span class="font10">tenofovir </span>
   <span class="font10">transcriptase </span>
   <span class="font10">type </span>
   <span class="font10">use, </span>
   <span class="font10">virus </span>
   <span class="font10">women </span>
   <span class="font10">would </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Africa </span>
   <span class="font10">CAPRISA </span>
   <span class="font10">Infect </span>
   <span class="font10">Tenofovir </span>
   <span class="font10">World </span>
   <span class="font10">[], </span>
   <span class="font10">acquiring </span>
   <span class="font10">also </span>
   <span class="font10">any </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">consent </span>
   <span class="font10">courier; </span>
   <span class="font10">critical </span>
   <span class="font10">delayed </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">exposure </span>
   <span class="font10">fourth-generation </span>
   <span class="font10">initiation </span>
   <span class="font10">less </span>
   <span class="font10">likely </span>
   <span class="font10">line </span>
   <span class="font10">manuscript. </span>
   <span class="font10">may </span>
   <span class="font10">nine </span>
   <span class="font10">pressure </span>
   <span class="font10">project </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">regimen </span>
   <span class="font10">result </span>
   <span class="font10">reverse </span>
   <span class="font10">setting </span>
   <span class="font10">settings </span>
   <span class="font10">stored </span>
   <span class="font10">their </span>
   <span class="font10">third-generation </span>
   <span class="font10">used </span>
   <span class="font10">wild </span>
  </p>
 </body>
</html>
